Published in Clin Chem on October 01, 1982
Association between plasma homocysteine and riboflavin status in Acute Lymphoblastic Leukemia in children. Indian J Clin Biochem (2009) 0.75
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
Therapeutic 131I in outpatients: a simplified method conforming to the Code of Federal Regulations, title 10, part 35.75. J Nucl Med (2000) 2.17
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab (1999) 1.92
Cancer mortality following treatment for adult hyperthyroidism. Cooperative Thyrotoxicosis Therapy Follow-up Study Group. JAMA (1998) 1.82
Ionizing irradiation and the induction of clinically significant disease in the human thyroid gland. Am J Med (1977) 1.61
Myoglobin as an early indicator of acute myocardial infarction. Ann Emerg Med (1987) 1.52
Thyroid nodularity and chromosome aberrations among women in areas of high background radiation in China. J Natl Cancer Inst (1990) 1.49
Biochemical studies on inositol. IX. D-Inositol 1-phosphate as intermediate in the biosynthesis of inositol from glucose 6-phosphate, and characteristics of two reactions in this biosynthesis. J Biol Chem (1966) 1.47
201Tl as a tumour-localizing agent: current status and future considerations. Nucl Med Commun (1993) 1.43
Measurement of cardiac troponin T is an effective method for predicting complications among emergency department patients with chest pain. Ann Emerg Med (1998) 1.41
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid (1998) 1.33
Imaging of bone metastases with 99m Tc-Sn-EHDP (diphosphonate), 18 F, and skeletal radiography. A comparison of sensitivity. Radiology (1973) 1.30
Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer. N Engl J Med (1983) 1.28
The impact of age and gender on papillary thyroid cancer survival. J Clin Endocrinol Metab (2012) 1.25
Metabolic disposition studies on simvastatin, a cholesterol-lowering prodrug. Drug Metab Dispos (1990) 1.25
Procedure guideline for somatostatin receptor scintigraphy with (111)In-pentetreotide. J Nucl Med (2001) 1.25
In vivo quantitation of lesion radioactivity using external counting methods. Med Phys (1976) 1.18
Time-dependent changes in the density and hemoglobin F content of biotin-labeled sickle cells. J Clin Invest (1998) 1.14
Fibrosing mediastinitis causing nonvisualization of one lung on pulmonary scintigraphy. Clin Nucl Med (1993) 1.13
pH-dependent oral absorption of L-735,524, a potent HIV protease inhibitor, in rats and dogs. Drug Metab Dispos (1995) 1.12
Biochemical studies on inositol. 8. Purification and properties of the enzyme system which converts glucose 6-phosphate to inositol. J Biol Chem (1965) 1.11
Successful storage of RBCs for 10 weeks in a new additive solution. Transfusion (2000) 1.10
Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animals. Drug Metab Dispos (1992) 1.10
Low iodine diet in I-131 ablation of thyroid remnants. Clin Nucl Med (1983) 1.09
Design and synthesis of a series of potent and orally bioavailable noncovalent thrombin inhibitors that utilize nonbasic groups in the P1 position. J Med Chem (1998) 1.08
Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor. Drug Metab Dispos (1996) 1.08
The effect of 1,25(OH)2 vitamin D3 supplementation in premature infants. J Pediatr (1978) 1.07
Kinetics of endothelial cell seeding. J Vasc Surg (1985) 1.06
Neonatal parathyroid function: role of gestational age and postnatal age. J Pediatr (1973) 1.06
A "do it yourself" family care program. Ohio State Med J (1971) 1.06
Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats. Drug Metab Dispos (1992) 1.01
The physiological disposition of lovastatin. Drug Metab Dispos (1989) 1.00
Neonatal hypermagnesemia: effect on parathyroid hormone and calcium homeostasis. J Pediatr (1980) 1.00
The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine. Int J Rad Appl Instrum B (1986) 0.99
Buffering and dilution in red blood cell storage. Transfusion (2006) 0.97
A comparison of methods for assessing patient body burden following 131I therapy for thyroid cancer. Radiology (1980) 0.97
Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in rats. Drug Metab Dispos (1988) 0.97
Procedure guideline for gallium scintigraphy in the evaluation of malignant disease. Society of Nuclear Medicine. J Nucl Med (1997) 0.96
Radiobiological evaluation of immigrants from the vicinity of Chernobyl. Int J Radiat Biol (1997) 0.94
Hematoporphyrin derivative uptake and photodynamic therapy in pancreatic carcinoma. J Surg Oncol (1988) 0.93
Outcome after treatment of high-risk papillary and non-Hürthle-cell follicular thyroid carcinoma. Ann Intern Med (1998) 0.91
Sex-dependent pharmacokinetics of indinavir: in vivo and in vitro evidence. Drug Metab Dispos (1996) 0.91
Effect of dexamethasone on the intestinal first-pass metabolism of indinavir in rats: evidence of cytochrome P-450 3A [correction of P-450 A] and p-glycoprotein induction . Drug Metab Dispos (1999) 0.90
Bone scintigraphy screening in stage I-II breast cancer: is it cost-effective? Cleve Clin J Med (1996) 0.90
Reverse redistribution phenomenon in thallium-201 stress tests: angiographic correlation and clinical significance. J Nucl Med (1985) 0.89
Studies on the mechanism of cyclization of glucose 6-phosphate to D-inositol 1-phosphate. Biochim Biophys Acta (1967) 0.89
The continuing impact of thyroid scintigraphy on the diagnosis of thyroid enlargement. Clin Nucl Med (1986) 0.88
Serum osteocalcin measurements in prostate carcinoma patients with skeletal deposits shown by bone scintigram: comparison with serum PSA/PAP measurements. J Nucl Med (1990) 0.88
Quantitative external counting techniques enabling improved diagnostic and therapeutic decisions in patients with well-differentiated thyroid cancer. Radiology (1977) 0.88
14C-tripalmitin breath test as a diagnostic aid for fat malabsorption due to pancreatic insufficiency. J Nucl Med (1974) 0.87
Isolated right superior vena cava draining into left atrium diagnosed by radionuclide angiocardiography. J Nucl Med (1973) 0.86
67Ga as a diagnostic agent for the detection of head and neck tumors and lymphoma. Radiology (1974) 0.86
A case of elevated spontaneous micronucleus frequency derived from chromosome 2. Mutat Res (1999) 0.85
The effect of fibronectin coating on endothelial cell kinetics in polytetrafluoroethylene grafts. J Vasc Surg (1986) 0.85
On the absorption of alendronate in rats. J Pharm Sci (1994) 0.85
Hypomagnesemia in infants of diabetic mothers: perinatal studies. J Pediatr (1976) 0.85
Strontium-89 therapy for the pain of osseous metastases. J Nucl Med (1985) 0.85
Regiospecific intestinal absorption of the HIV protease inhibitor L-735,524 in beagle dogs. Pharm Res (1995) 0.85
Increased gut blood flow with early enteral feeding in burned guinea pigs. J Burn Care Rehabil (1989) 0.85
Tc-99m diphosphonate and sulfur colloid uptake by the spleen in sickle disease: interrelationship and clinical correlates: concise communication. J Nucl Med (1984) 0.84
Thrombogenicity of a fibronectin-coated, experimental polytetrafluoroethylene graft. Surgery (1987) 0.84
Metabolites of L-735,524, a potent HIV-1 protease inhibitor, in human urine. Drug Metab Dispos (1995) 0.84
Clinical significance of serum vitamin B12 measured by radioassay using pure intrinsic factor. J Nucl Med (1981) 0.84
Idiopathic pulmonary ossification with focal pulmonary uptake of technetium-99m HMDP bone scanning agent. Clin Nucl Med (1985) 0.83
Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. J Nucl Med (1993) 0.83
Treatment of polycythemia vera with hydroxyurea. Am J Hematol (1984) 0.83
Radionuclide imaging. Use in diagnosis of osteomyelitis in children. JAMA (1977) 0.83
Improved oral absorption of L-365,260, a poorly soluble drug. Biopharm Drug Dispos (1996) 0.83
Discovery of a novel, selective, and orally bioavailable class of thrombin inhibitors incorporating aminopyridyl moieties at the P1 position. J Med Chem (1997) 0.83
Vasopressin-resistant diabetes insipidus associated with short-term demethylchlortetracycline (declomycin) therapy. Mil Med (1973) 0.82
A statistical method for determining normal ranges from laboratory data including values below the minimum detectable value. Clin Chem (1979) 0.82
An evaluation of undergraduate family care programs. J Community Health (1978) 0.82
The value of hepatobiliary scans in fasted patients receiving total parenteral nutrition. Surgery (1987) 0.82
I-123 MIBG scintigraphy in adults. A report of clinical experience. Clin Nucl Med (1995) 0.82
Efficacious, orally bioavailable thrombin inhibitors based on 3-aminopyridinone or 3-aminopyrazinone acetamide peptidomimetic templates. J Med Chem (1998) 0.81
Familial hyperparathyroidism. Description of a large kindred with physiologic observations and a review of the literature. Ann Intern Med (1976) 0.81
Successful storage of RBCs for 9 weeks in a new additive solution. Transfusion (2000) 0.81
Radiation-associated carcinoma of the salivary glands. A controlled study. Ann Otol Rhinol Laryngol (1981) 0.81
L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor. Bioorg Med Chem Lett (1998) 0.80
Calculating lens dose and surface dose rates from 90Sr ophthalmic applicators using Monte Carlo modeling. Med Phys (1998) 0.80
Whole body and partial body radiotherapy of advanced cancer. Am J Roentgenol Radium Ther Nucl Med (1973) 0.80
A pathophysiologic study of the hypertension associated with burn injury in children. Ann Surg (1981) 0.80
Causes of abnormalities reported in nuclear medicine testing. J Nucl Med (1976) 0.80
Route-dependent nonlinear pharmacokinetics of a novel HIV protease inhibitor: involvement of enzyme inactivation. Drug Metab Dispos (2000) 0.79
Visualization of alcohol-induced rhabdomyolysis: a correlative radiotracer, histochemical, and electron-microscopic study. J Nucl Med (1979) 0.79
Radon update: facts concerning environmental radon: levels, mitigation strategies, dosimetry, effects and guidelines. SNM Committee on Radiobiological Effects of Ionizing Radiation. J Nucl Med (1994) 0.79
Clinically important radiation-associated thyroid disease. A controlled study. JAMA (1980) 0.79
Radiation absorbed-dose estimates for the liver, spleen, and metaphyseal growth complexes in children undergoing gallium-67 citrate scanning. Radiology (1983) 0.79
Identification of MK-944a: a second clinical candidate from the hydroxylaminepentanamide isostere series of HIV protease inhibitors. J Med Chem (2000) 0.79
Multimodality imaging of osteomyelitis. Eur J Nucl Med (1995) 0.79
Treatment of metastatic bone pain with tin-117m Stannic diethylenetriaminepentaacetic acid: a phase I/II clinical study. Clin Cancer Res (1998) 0.78
Dosage and response in radiopharmaceutical therapy of painful osseous metastases. J Nucl Med (1996) 0.78
Competitive heterogeneous enzyme immunoassay for digoxin with electrochemical detection. Anal Chem (1986) 0.78
Synthesis and renal excretion of technetium-99m-labeled organic cations. J Nucl Med (1992) 0.78
Early burn wound excision and skin grafting postburn trauma restores in vivo neutrophil delivery to inflammatory lesions. Arch Surg (1988) 0.78